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Intellectual disability (ID), previously known as mental retardation, affects 3% of the pop-
ulation and remains without pharmacological treatment. ID is characterized by impaired
general mental abilities associated with defects in adaptive function in which onset occurs
before 18 years of age. Genetic factors are increasing and being recognized as the causes
of severe ID due to increased use of genome-wide screening tools. Unfortunately drug
discovery for treatment of ID has not followed the same pace as gene discovery, leaving
clinicians, patients, and families without the ability to ameliorate symptoms. Despite this,
several model organisms have proven valuable in developing and screening candidate
drugs. One such model organism is the fruit fly Drosophila. First, we review the current
understanding of memory in human and its model in Drosophila. Second, we describe
key signaling pathways involved in ID and memory such as the cyclic adenosine 30,50-
monophosphate (cAMP)–cAMP response element binding protein (CREB) pathway, the
regulation of protein synthesis, the role of receptors and anchoring proteins, the role of
neuronal proliferation, and finally the role of neurotransmitters. Third, we characterize the
types of memory defects found in patients with ID. Finally, we discuss how important
insights gained from Drosophila learning and memory could be translated in clinical
research to lead to better treatment development.
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Introduction
Intellectual disability (ID), previously known asmental retardation, is a commonneurodevelopmen-
tal disorder affecting 3% of the population and frequently a lifelong condition (1, 2). ID is defined
by impaired general mental abilities and adaptive functions with an onset before the age of 18 (3).
Adaptive functions are divided into three main categories: (i) conceptual, which includes reasoning,
executive function, and problem solving; (ii) social, which involves interpersonal communication
and relationship; and (iii) practical, which involves personal care and activities of daily living
(3). Mental abilities are assessed with intelligence tests such as the Weschler Scale Intelligence in
Children, which includes verbal and non-verbal components. ID has been defined with intellectual
quotient (IQ) scores less than 70. ID’s severity is frequently based on IQ: Mild ID 51–70, moderate
36–49, severe 21–35 and profound<20.
Intellectual disability can present as isolated cognitive defects or in association with other
symptoms or physical signs. ID patients should be assessed for co-morbid conditions such as
autism, epilepsy, anxiety, obsessive-compulsive disorder, and sleep disorders (4) (Figure 1). Physical
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signs can be characteristic facial or body features (known as dys-
morphism) or evenmagnetic resonance imaging (MRI) structural
abnormalities. The systematic association of specific signs has
been defined as syndromic ID. Non-syndromic ID represents the
other ID patients without clear dysmorphic or MRI malforma-
tions. Syndromic ID facilitates the clinical diagnosis of individuals
but has also allowed for faster gene discovery and can still facilitate
the interpretation of results in exome or genome sequencing by
increasing the number of patients whose genome can be com-
pared for common mutations. Traditional syndromes have been
recognized and mapped to specific gene regions (Table 1). It is
important to note that some syndromes are more frequent in
specific populations and should therefore be screened first. For
instance, a high rate of carrier for the mutation causing Tay Sachs
is seen in Ashkenazi Jews and a high incidence of Bardet Biedl
is found in Bedouin family. The study of ID syndromes has also
revealed that a given phenotype can be caused by multiple genes.
A good example of this is with the Rett syndrome, for which the
MeCP2 genes is identified in classical patients (4) but for whom,
variant cases have been associated with FOXG1 (5, 6), CDKL5
(7). Conversely, a single gene can have multiple phenotypes. For
Abbreviations: 4EBP, eukaryotic translation initiation factor 4E-binding protein
1; AKT, serine/threonine-specific protein kinase; AMPA, α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid; aru, arouser; ASD, autism spectrum disor-
ders; ATP, adenosine triphosphate; cAMP, cyclic adenosine 30,50-monophosphate;
CBP/CREBBP, CREB-binding protein; CGH, comparative genomic hybridization;
CNS, central nervous system; CPEB, cytoplasmic polyadenylation element binding
protein; CREB, cAMP response element binding protein; CRTC, CREB regulated
transcription coactivator 1; DAL, dorso-anterior-lateral neurons; DCO, Drosophila
PKA catalytic subunit; dCREB, Drosophila cAMP-response element binding pro-
tein; dfmr1, Drosophila fragile X mental retardation 1; DmGluRA, drosophila
group II metabotropic glutamate receptor gene; dnc, dunce; dnc-PDE, dunce
encoded cAMP-specific phosphodiesterase; dNR1, defense repressor 1; dNR2,
defense repressor 2; DS, Down syndrome; Dscam, Down syndrome cell adhesion
molecule; DSCR1, Down syndrome critical region 1 gene; dTSC1, Drosophila
tuberous sclerosis complex 1; dTSC2, Drosophila tuberous sclerosis complex 2;
Egfr, epidermal growth factor receptor signaling pathway; EPS8/Esp8, epidermal
growth factor receptor kinase substrate 8; fLTM, fasting-dependent long-term
memory; FMR1, fragile X mental retardation 1; FMRP, fragile X mental retardation
protein; FOXG1, forkhead box protein G1; FX, fragile X; FXS, fragile X Syndrome;
Gαs, alpha subunit of the heterotrimetric G protein; GDP, guanosine diphos-
phate; GTP, guanosine-50-triphosphate; ID, intellectual disability; IQ, intellectual
quotient; LD, learning disability; LTM, long-term memory; MB, mushroom body;
MeCP2, methyl-CpG-binding protein 2; mGluR, metabotropic glutamate recep-
tors; Mnb, minbrain; MP1, mushroom body innervating dopaminergic neuron P1
cluster in protocerebrum; MRI, magnetic resonance imaging; mRNA, messenger
ribonucleic acid; MRX, mental retardation X linked; mTOR, mammalian target
of rapamycin; mTORC1, mammalian target of rapamycin complex 2; mTORC2,
mammalian target of rapamycin complex 1; MV1, mushroom body innervating
dopaminergic neuron V1 cluster in protocerebrum; Nf1/NF1, neurofibromatosis
type 1; nla, nebula; NMDAR, N-methyl--aspartate receptor; Orb2, oo18 RNA-
binding protein 2; PDE, phosphodiesterase; PI3K, phosphatidylinositol (3,4,5)-
trisphosphate; PIP3, phosphatidylinositol 3,4,5 trisphosphate; PKA, protein Kinase
A; PNH, periventricular nodular heterotopia; PSD, postsynaptic domain; Q/N,
glutamine/asparagine; RHEB, RAS homolog enriched in brain; rut, rutabaga; Rut-
AC, rutabaga encoded type 1 Ca2+/calmodulin-activated adenylyl cyclase; RNA,
ribonucleic acid; RSK2, ribosomal S6 kinase; RTS, rubinstein-taybi syndrome; S6K,
ribosomal protein S6 kinase; SHANK2, SH3 and multiple ankyrin repeat domains
protein 2; SHANK3, SH3 and multiple ankyrin repeat domains 3; SOX, SRY-related
high mobility groove box; SOX3, SRY (sex determining region Y)-box 3; spLTM,
spaced training long-term memory; STM, short-term memory; synj, synaptojanin;
TSC1, tuberous sclerosis complex 1; TSC2, tuberous sclerosis complex 2; UBE3A,
ubiquitin protein ligase E3A; WES, whole exome sequencing.
instance, silencing of the Fragile X gene can lead to classical
Fragile X syndrome (FXS) or to its Prader–Willi variant, which is
characterized by increased appetite and weight gain (8).
The widespread use of genome-wide techniques such as com-
parative genomic hybridization (CGH) (9) and more recently
whole exome sequencing (WES) (10) in patients with ID has
allowed for the identification of an increasing number of genetic
defects in patients with ID, although in many milder cases a cause
can still not be identified (11). Indeed over 528 genes have been
found (12) and over 1700 genes are associated with ID in OMIM.
A large number of genes have been mapped to the X chromosome
[termed MRX and reviewed in Ref. (13)] and account for 5–10%
of cases in males (14).
It is important to note that the differential diagnosis for ID also
includes cortical malformation, cerebral infections, and ischemic
changes that underline the importance of performing MRI in
patients with ID.Moreover, ID can also be caused by environmen-
tal exposure to drugs, alcohol, or toxins such as lead. In addition,
metabolic disorders (see http://www.treatable-id.org/ for a list of
disorders) and endocrine dysfunction (such as hypothyroidism)
must be ruled out.
Intellectual disability remains without treatment and this can
be explained, at least in part, by our lack of understanding of
the role of the affected genes in cognitive development. Several
animal models have been developed to study the genetic basis of
ID, one of which is Drosophila. Despite its evolutionary distance
to mammals, Drosophila has shown positive response to drugs
that were later shown to also work in mammals. For instance,
metabotropic glutamate inhibitor drugs found to rescue memory
inDrosophilamutant for the FXS gene (15, 16), the most common
single gene cause of ID, also rescues memory in mouse FXS
models (17). However, using related compounds in humans failed
to show efficacy in recent clinical trials, causing concerns (18,
19). This lack of translation could be caused by several reasons,
including the higher level of complexity of the human brain and
the increased genetic heterogeneity of humans. Here, we review
aspects of Drosophila memory studies that may shed light on ID
treatment.
First, we will review the basics of learning and memory clas-
sification in humans and animal models. Second, we will discuss
key cellular mechanisms involved in memory and ID such as the
cAMP–CREB pathway, the role of protein synthesis, the function
of receptors and anchoring proteins, the role of cell proliferation,
and finally the role of neurotransmitters. Third, we will go back
to the concept of memory defects in patients with ID and analyze
the evidence for such defects in ID patients. Finally, we will dis-
cuss key questions relevant to clinical trials for which Drosophila
learning and memory research may have provided important
mechanistic insights.
Memory Formation in Humans and Drosophila
As mentioned above, the IQ test and ability to learn are at the
center of the diagnosis of ID. One of the components of the IQ
test is aimed at assessing memory. The study of learning and
memory in healthy human subjects was pioneered by Ebbing-
haus, who used non-sense word memorization to study memory
formation and recall (20). Memory can be classified in several
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FIGURE 1 | Intellectual disability and related co-morbid conditions.
Intellectual disability is defined by the presence of cognitive defects (as
measured usually by an intellectual quotient below 70) and the presence of
adaptive dysfunction. These symptoms must have an onset before the patient
is 18 years old to distinguish it from other conditions such as dementia.
Several other conditions are frequently associated with ID, including sleep
difficulties, obsessive-compulsive behaviors, anxiety, sensory-processing
difficulties, autism, and epilepsy, which have significant effect on the cognitive
and adaptive behaviors of the patients. In many patients, the effect of anxiety
can be so prominent that it leads to underestimation of the true cognitive
potential. Sensory-processing deficit is also very important in regulating the
perception of sound, light and pain, and can contribute to the anxiety. Autism,
which involves limited behavioral and social repertoire, will also affect the
ability of the child to interact and thus impact his development. Epilepsy is
much more common in ID (up to 30% as opposed to 3% in the general
population) and can have detrimental effect on memory and daily functioning.
In addition, drugs used to treat epilepsy (such as valproic acid) may have
effects on memory themselves.
ways: based on temporal pattern, types of information stored,
or region of the brain involved in the storage. In the temporal
classification, memory can be defined as short-term memory
(usually tested a few seconds to a minute after the training) or
long-term memory (usually 1 day or 1week after the training).
This type of temporal classification has been widely used in the
Drosophila study of memory. In humans, short-term memory is
also sometimes referred to as workingmemory.Workingmemory
has been divided conceptually by Baddeley and Hitch (21) into:
central executive, a phonological loop, and visuo-spatial sketch-
pad. Memory can also be classified by the type of memories being
stored, implicit or explicit (22). Implicit memory involves the
learning of motor skills and depends on basal ganglia and cerebel-
lum. It is spared in hippocampal lesions as shown in the patient
HM [reviewed in Ref. (23)]. On the other hand, explicit memory
relates to facts (semantic type) or to events (episodic) (24).
Several paradigms have been used to study learning and mem-
ory formation in Drosophila and include: olfactory, courtship,
appetitive, visual, and place memory. Here, because of limited
space, we will focus on classical olfactory conditioning, which
involves the pairing of an odor with a footshock. Benzer pioneered
the assay by training flies using the phototaxis response of flies
to induce climbing to a chamber containing an electrified grid
where flies would receive a footshock at the same time as an
odor was presented (25). Flies would then be allowed to climb
to another chamber to receive a second odor but this time with-
out footshock. In 1985, Tully and Quinn modified the assay to
allow for the presentation of the odor and the shock in the same
chamber without the need for phototaxis (26). This simplified
method allowed for higher performance. Using both forward
and reverse genetic approaches, several laboratories were able to
identify several genes involved in learning and memory that will
be described below in Section “Overlap between the Genetics of
Memory in Drosophila and Intellectual Disability.” As mentioned
above, other assays were also developed to take advantage of the
power of fly genetics. Indeed, memory of courtship has also been
used extensively and relies on the ability of the fly to remember
if a female has been courted [reviewed in Ref. (27)]. Appetitive
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TABLE 1 | Common causes of Intellectual disability.
ID syndrome ID gene Prevalence Clinical phenotype Heritabilty Drosophila
memory
GENERAL POPULATION
Fetal alcohol syndrome NA 1/200-2000 ID Not tested
Down syndrome Down syndrome critical
region 1 (DSCR1)
1/650 ID, systemic manifestations Autosomal/maternal age Learning+ LTM
Down syndrome Down syndrome cell
adhesion molecule (DSCAM)
1/650 ID, systemic manifestations Autosomal/maternal age Learning
Neurofibromatosis NF1 1/3500 ID, attention difficulty, Tumors Autosomal
dominant/sporadic
Learning+ LTM





TSC 1 and TSC2 1/12,000 ID, autism, seizures, tumors,
systemic manifestations
Autosomal dominant Not tested
Angelman syndrome UBE3A 1/15,000 ID, seizures, autism Autosomal/maternal
transmission
LTM





Cri du Chat CTNND2, TERT 1/20,000 ID, systemic manifestations 90% de
novo/translocation
Not tested
Williams syndrome ELN,CLIP2,GTF2I, LIMK1 1/20,000 ID, systemic manifestations Autosomal
dominant/sporadic
Not tested





CREB-binding Protein 1/100,000 ID sporadic Not tested
Mental retardation
autosomal recessive 1
Neurotrypsin Not known ID Autosomal recessive LTM
SPECIFIC POPULATIONS
Tay Sachs Hexoaminidase A 1/35,000 (jews) ID, regression Autosomal recessive Not tested
Bardet-Biedl BBS1 1/13,000 (Bedouin) ID, systemic manifestations,
obesity
Autosomal recessive Not tested
Cockayne ERCC8 1/300,000 ID, progyria Autosomal recessive Not tested
Cornelia De Lange NIPBL 1/200,000 ID, systemic manifestations Autosomal
dominant/sporadic
Not tested
Phenylketonuria PAH 1/10,000 ID, systemic manifestations,
blond hair
Autosomal recessive Not tested
Some of the most commonly seen causes of ID are listed by order of frequency. Some causes are rare in the general population but should be investigated in the high risk specific
ethnic groups. Note that the focus is on genetic causes, several other non-genetic causes need to be ruled out and are described in the Section “Memory Formation in Humans and
Drosophila.”
memory is another commonly used paradigm for memory based
on positive reinforcement (28).
In addition to identifying genes involved in memory, the assay
has allowed the dissection of the persistence of memory as a
function of the training provided and the time elapsed since that
training. Short-term memory, also known as learning, relates to
the memory formed after a single-training session and is tested
a few minutes following training. This form of memory is linked
with receptor activation and activation of intracellular signaling
cascade of secondary messengers but does not require de novo
transcription (RNA synthesis) or translation (protein synthesis).
In Drosophila, this memory decays rapidly after 1 day. Intermedi-
ate memory has been less well studied and is formed after short-
term memory. It depends on the gene amnesia (29). However,
some memory can persist up to 1week, even in flies, and is
labeled as long-termmemory. Long-termmemory is formed after
repeated training sessions and is both translation and transcrip-
tion dependent (30, 31).
Memory studies in Drosophila have also shown that different
stages of memory depend on various brain regions. The mush-
room bodies are required for learning (32). In addition, activity in
the mushroom body (MB) innervating neurons (MV1 and MP1
dopaminergic neurons) was shown to be required for long-term
memory (33). But more recently, it has been shown that protein
synthesis in the dorso-anterior-lateral neurons (DAL) is required
for long-term memory formation (34). Memory in flies activates
different regions as it goes from short-termmemory to long-term
memory [reviewed in Ref. (35)]. Several lines of research suggest
that information processed by the mushroom bodies could then
be stored in the central complex (36). This parallels findings in
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mammals showing transfer of memory from the hippocampus
to the cortex. In humans, information is initially stored in the
hippocampus and is later transferred for long-term storage in the
cortex for explicit memory and into the cerebellum and basal
ganglia for implicit (or procedural memory). This is an important
concept in drug discovery and translating any discoveries to other
animal models and to human clinical trials because study done
in the laboratory in a certain cortical or subcortical area may not
translate to other regions or to the global brain function.
Overlap Between the Genetics of Memory
in Drosophila and Intellectual Disability
An important overlap has emerged between genes identified
in Drosophila memory basic research and genes identified in
patients with ID (37). This convergence reinforced the use of
the learning and memory models in order to understand the
molecular basis of ID. The goal of many reverse genetics studies
is to provide insights into the link between gene mutation and
cognitive phenotype. We have selected a few pathways to discuss
them more in depth, but several other important pathways have
been reviewed elsewhere (38).
Cyclic Adenosine Monophosphate Signaling Pathway
The cAMP pathway was the initial pathway identified in the
forward genetic study of learning in Drosophila. The pathway is
usually activated via the G-coupled protein. The alpha subunit
of the heterotrimetric G protein (Gαs) encodes a GTPase that
hydrolyzes GTP to GDP. Mutations in Gαs inhibit the conversion
of GTP to GDP, resulting in a constitutively active form of Gαs
(39, 40). Gαs modulates cAMP signaling by activating rutabaga,
an adenylyl cyclase, which is responsible for cAMP production.
Constitutive activation of Gαs in Kenyon cells produces a learning
and memory defect in Drosophila similar to the ablation of the
MB, a key region in memory formation (41).
The Drosophila mutant rutabaga (rut) was identified early
in the study of Drosophila learning and encodes a type 1
Ca2+/calmodulin-activated adenylyl cyclase (rut-AC) (42, 43).
Rut-AC is a coincidence detector that requires stimulation
through G-protein and Ca2+/calmodulin to regulate cAMP levels
(44, 45). ATP enzymatic conversion to cAMP ismediated through
the interaction of the Ca2+ binding activity of calmodulin with
adenyl cyclase activity that results in an increase in cAMP levels.
Rut is required for learning, short-term memory, and long-term
memory (46, 47). The degradation of cAMP is performed through
phosphodiesterase (PDE). Dunce (dnc) encodes a cAMP-specific
phosphodiesterase (dnc-PDE) that is required for learning and
leads to the degradation of cAMP (48, 49). Early studies showed
that flies with mutation of both dunce and rutabaga combined
had significant learning defects (26, 45). Testing of cAMP levels
showed that despite showing low levels of both PDE and AC, the
dnc rut double mutants had persistently slightly elevated cAMP
levels when compared to wild-type flies. Those measurements
were made in the abdomen and it remains therefore unknown
if brain measurements were also mildly elevated (45). There-
fore, antagonizing an enzyme to counterbalance an excess in
signaling may not be sufficient in re-establishing normal levels of
biomarkers (such as cAMP levels) and may not be sufficient to
rescue cognitive defects.
The cAMP-Dependent Protein Kinase (PKA) is a downstream
effector of cAMP signaling. An increase in cAMP levels triggers a
phosphorylation cascade through the activation of protein kinase
A (PKA), and initiates transcription of learning and memory
genes (48, 50). Increased levels of cAMP leads to the activation
of PKA, DCO is theDrosophila PKA catalytic subunit (51). Muta-
tions in the regulatory and catalytic subunits of DCO results in
learning and medium-term memory deficits (52–55).
Following activation of PKA or other kinases such as RSK2, the
cAMP-Response Element Binding Protein (dCREB2) is phospho-
rylated, which activates transcription of genes containing aCREB-
binding site (56). dCREB2 encodes the transcription factor cAMP
response element binding protein (57). dCREB2 is required for
long-termmemory formation (30, 31, 58). Experimental evidence
suggests that CREB protein is required for higher brain functions
of MB, which is known to be required for several forms of learn-
ing and memory in Drosophila and dorsal-anterior-lateral (DAL)
neurons. These two regions are joined by synaptic connections,
which suggest an interaction between these regions during mem-
ory formation and provides a link to the role of CREB in LTM
regulation.
Cyclic adenosine monophosphate response element-binding
protein’s role in memory is dependent on the nutritional sta-
tus of the flies though. Hirano found that aversive LTM for-
mation occurred after single-cycle training when mild fasting
was applied before training (59). Both fasting-dependent LTM
(fLTM) and spaced training–dependent LTM (spLTM) required
protein synthesis and cyclic adenosine monophosphate (cAMP)
response element-binding protein (CREB) activity. However,
spLTM required CREB activity in two neural populations: MB
and DAL neurons, whereas fLTM required CREB activity only
in MB neurons (60). fLTM uses the CREB coactivator CRTC,
whereas spLTM uses the coactivator CBP. In addition to the
change in co-factor requirement, starvation was shown to change
neuronal activity in dopaminergic neurons activated by memory
training (60).
Several ID genes have been shown to affect the cAMP–CREB
pathway. An important ID gene linked to Drosophila memory
was the human CREB-binding protein (CBP or CREBBP). As
mentioned above, CREB requires the co-factor CBP. CBP has
been found to be mutated in patients with Rubinstein–Taybi syn-
drome (RTS) (MIM180849) (61), a rare cause of syndromic ID.
Drug rescue with PDE inhibitors was shown in the mouse model
of RTS (62).
Another important ID gene linked to the cAMP pathway
is Neurofibromin (NF1) (MIM 613113), which encodes a Ras-
specific GTPase-activating protein (GAP) (63). In neurofibro-
matosis type 1 (NF1), the NF1 gene contains mutations that alter
functioning of this protein. NF1 is a neurocutaneous syndrome in
which patients have skin and brain symptoms and signs. Patients
with NF1 suffer from attention difficulty, learning disabilities, and
intellectual disabilities. ADrosophila homolog of NF1 is expressed
broadly in the adult fly brain including key structures associ-
ated with learning and memory such as the MB, lateral horn,
and antennal lobes (64). NF1 regulates adenylyl cyclase activity
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(rut-AC) and cAMP production (41, 63, 65–68). NF1 acts as
a GAP on Gαs thereby altering rut-AC dependent synthesis of
cAMP. NF1 is required for memory acquisition and short-term
memory but interestingly, different domains are required for each
phase of memory (69).
Finally, the ID gene Fragile X mental retardation 1 (FMR1)
(OMIM309550) has also been shown to affect the cAMP pathway.
FMR1 is mutated in patients with FXS, themost common cause of
ID in boys. Berry-Kravis showed that cAMP levels in response to
activation (with forskalin) were lower in patients with FXS (70).
Drosophila has a highly conserved homolog of FMR1 (71), dfmr1.
Dfmr1 regulates local mRNA translation in dendrites (72, 73).
Drosophila mutant for dfmr1 has been shown to have courtship
and olfactory learning andmemory defects. Recently, FXmemory
defects in Drosophila were shown to be reversed by treatment
with PDE inhibitor (74, 75). Moreover, CREB level circadian
fluctuations have been shown to be defective in FX-mutant flies. In
addition, higher levels of FMRP are seen in PDEmutants (15, 74).
Protein Synthesis and Degradation
Interestingly though, FMR1 is not only involved in cAMP signal-
ing but is also involved in control of protein synthesis (Figure 2).
FIGURE 2 | Fragile X Mental retardation protein regulates several cellular
functions in the dendritic spine. Fragile X Mental retardation protein affects
multiple aspects of neuronal metabolism. Even within a certain function like
translational control, FMRP interacts with multiple pathways. Indeed, FMRP has
been shown to regulate the AKT pathway via repression of PIKE. In addition,
FMRP regulates CPEB that regulates translation via the poly A tail. FMRP also
binds CYFIP and is part of the microRNA and short interfering pathway. FMRP
also regulates the assembly of the ribosome to target RNA with the short RNA
BC1. FMRP also interact with the cAMP–CREB pathway via the link with PKA
but also because FMRP is produce in response to CREB activation. FMRP
regulates cellular shape via actin remodeling using multiple molecules (profilin,
cofilin, filamin) and receptors (Dscam, Receptor tyrosine kinase-RTK).
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Early biochemical studies showed a global up-regulation of pro-
tein synthesis in FX (76–80). FMRP is an RNA binding protein
for which several targets have been identified (77, 81–83). We
showed that excess protein synthesis was deleterious to mem-
ory in Drosophila but could be reversed with the protein syn-
thesis inhibitors, cycloheximide and puromycin (15). FMRP has
been shown to regulate protein synthesis via the AKT pathway,
microRNA (15), and CPEB (84). Indeed, Sharma et al. showed
that AKT signaling was enhanced in the mouse model of FX (85).
This was followed by the demonstration of excess AKT signaling
in the Drosophila larva brain (86). Loss of FMRP results in the
over-activation of mGluRs (74), which will be discussed in the
next section on receptors.
The PI3K–mTOR pathway includes other ID genes: TSC1 and
TSC2. The Drosophila Tuberous sclerosis (dTsc1 and dTsc2) is
homologs of TSC1 and TSC2, which are mutated in patients with
Tuberous Sclerosis complex (OMIM 191100; OMIM 191092).
Patients affected by TSC have brain, skin, heart, kidney, eyes, and
lung defects. Cognitive symptoms will include ID and autism.
dTsc1 and dTsc2 function downstream of PI3K/AKT. dTsc1 and
dTsc2 form a heterodimeric complex in which dTsc2 is the cat-
alytic subunit containing a GAP domain for RHEB (87). Over-
expression of RHEB in Drosophila resulted in defect in 3-h
appetitive memory leaving the immediate memory intact (88).
Mutations in TSC genes lead to excess protein synthesis (sim-
ilar to FX) (89–91). Downstream of TSC genes is the Mam-
malian Target of Rapamycin (mTOR).mTOR is a serine/threonine
kinase that belongs to the phosphatidylinositol 3-kinase-related
protein family. mTOR functions as part of two distinct signal-
ing complexes, mTORC1 and mTORC2. Both mTORC1 and
mTORC2 function at synapses to regulate mRNA translation
(92–94). mTORC1 is activated through the direct binding of
RHEB. mTORC1 targets and phosphorylates eukaryotic initia-
tion factor 4E binding proteins (4EBPs) and ribosomal protein
kinases (S6Ks) (89). S6K in turn targets other translation regu-
lators (95). Inhibiting the function of mTORC1 creates defects
in long-term memory formation (96, 97). mTORC2 can be
directly activated through the PI3K pathway via phosphatidyli-
nositol (3,4,5)-trisphosphate (PIP3) (98). mTORC2 activity is ele-
vated during stimuli-associated learning and has recently been
identified to have a role in mGluR dependent long-term depres-
sion (94). Recently, it was shown that removal of the down-
stream target S6K in FX mutant mice rescues behavioral defects
including memory, reinforcing the role of protein synthesis
in FX (99).
A novel gene involved in the AKT pathway is Arouser (aru).
Aru has been implicated in short-term memory deficits in
Drosophila in a background-specific manner (100). Although not
fully characterized in Drosophila, aru is homologous to mam-
malian to the Epidermal growth factor receptor kinase substrate
8 (EPS8) protein family, Eps8L3 (101). Eps8L3 is an actin-capping
protein that functions in the epidermal growth factor recep-
tor signaling pathway (Egfr) as well as the PI3K/AKT signaling
pathway and is needed for normal spine morphology, synaptic
plasticity, and memory formation (102). Abnormal spine mor-
phology has been associated with ID and autism (103, 104).
Esp8 knockout mice exhibit learning and memory impairment
(105). Furthermore Eps8 levels are decreased in patients with
autism (105).
Another important regulator of protein synthesis is the
cytoplasmic polyadenylation element binding protein (CPEB).
oo18 RNA-binding protein 2 (Orb2) is an important mem-
ber of the CPEB family. Orb2 regulates local mRNA trans-
lation at pre- and post-synaptic compartments (106–110). In
Drosophila, Orb2 is specifically required in MB γ neurons for
long-term memory formation (111). Orb2 encodes two isoforms,
Orb2A and Orb2B (111). Orb2A and Orb2B differ in their N-
terminal domains, but have similar C-terminal domains. Together
Orb2A and Orb2B form a heterodimeric complex, this inter-
action is mediated through the Q-domain of Orb2A that func-
tion at synapses (112). The Q-domain of Orb2A is specifically
required for long-term memory but not short-term memory
(112). FMRP has been shown also to interact with Orb pro-
teins in protein translation regulation (84). Interestingly, spe-
cific FMRP isoforms without the glutamine/asparagine (Q/N-)
are required for LTM when most isoforms, which contain Q/N
rich sequence in the C-terminal region of the protein are suffi-
cient for STM (113). The Q/N-isoform shows a predominantly
nuclear localization and has been hypothesized to relate to reg-
ulation of chromatin and mRNA splicing and transport (114)
(Figure 3). The interaction between FMRP and CPEB has been
also confirmed in the Richter lab who showed that decreasing
CPEB activity in mouse could rescue memory defects seen in
FX mice (115).
Protein levels are also regulated through their degradation.
Ubiquitin-dependent proteasome degradation is an important
pathway for protein degradation. Mutation in the maternally
inherited copy of the ubiquitin ligase UBE3A have been identified
in 65–75% of Angelman syndrome (OMIM 105830) cases (116).
The remainder of cases is linked to paternal uniparental disomy,
imprinting defects, and UBE3A mutations (117). The Drosophila
model of Dube3A has shown that Dube3A is required for synaptic
potentiation and long-term synaptic depression (118, 119) and
that disruption of Dube3A leads to robust behavioral defects,
including deficits in climbing activity, circadian rhythms, and
long-term associative olfactory memory (120).
The serine-protease neurotrypsin was also shown to be impor-
tant in cognition in both human and flies (121). Indeed, humans
with neurotrypsin mutations suffered from autosomal reces-
sive ID whereas Drosophila showed long-term memory specific
defects.
Receptors, Anchoring Proteins, and
Neurotransmitters
Drosophila group II metabotropic glutamate receptor gene
(DmGluRA) has gathered a lot of interest with its implication in
FXS (122–124). DmGluRAs are G-protein-coupled receptors that
are present in MB calyces (125, 126). The binding of glutamate
to the receptor results in the down-regulation of neuronal activity
via AMPA receptors internalization in a protein synthesis/PI3K-
dependent manner (127).
Indeed, Huber showed that the enhanced long-term depression
in FX hippocampus was triggered by excessive mGluR activity.
This is because FMRP regulates the protein synthesis-dependent
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FIGURE 3 | FMRP also acts at the nuclear level. FMRP has been shown to
be produced in response to cAMP–CREB activation. Indeed, levels of FMRP are
increased in PDE mutants. FMRP isoforms have been shown to have different
role in short-term and long-term memory as was shown previously in NF1. The
FMRP isoform lacking the Q/N rich domain is localized back to the nucleus and
may participate in histone modification and splicing.
internalization of AMPA receptors in addition to the levels of
mGluR. The net result of the excess protein synthesis in absence
of FMRP was enhanced internalization of AMPA receptors. Fol-
lowing that, mGluR inhibition in Drosophila FX mutants was
shown to rescue memory defects (15, 16). There is also a feedback
loop wherein activation of mGluRs usually up-regulates FMRP
through the cAMP-CREB pathway (128, 129).
DrosophilaNMDA receptors 1 and 2 (dNR1 and dNR2) encode
NMDAR receptors that regulates excitatory neurotransmission
via glutamate (130). Synaptic changes occur following the binding
of glutamate to the receptor and the subsequent membrane depo-
larization that results in Ca2+ influx into post-synaptic cells (131).
Mutations and disruptions to the expression of dNR1 impair
learning and long-termmemory (130, 132). Recently, anti-NMDA
receptors antibodies encephalitis was shown to be the cause of
autism-like symptoms (133).
Down syndrome (MIM 190685) represents the most common
cause of ID and is caused by trisomy of chromosome 21. It causes
a syndromic ID associated with progressive dementia as well as
a host of other systemic manifestation. A critical region has been
recognized within chromosome 21. Nebula (nla) the Drosophila
homolog of Down syndrome critical region 1 gene (DSCR1)
encodes a calcipressin that binds to and inhibits calcineurin, and is
required for learning and long-termmemory (134). Calcineurin 1
is regulated by nla by inhibiting calcineurin-mediated signaling
(135). Altered nla expression results in learning and memory
defects. Calcineurin targets and up-regulates the activity of synap-
tojanin (synj) via its dephosphorylation (136). Synj encodes a
phosphatidylinositol phosphatase that functions in endocytosis
(137). Minbrain (Mnb), which encodes a serine/threonine kinase,
targets and phosphorylates synj (138). Synj and nla are overex-
pressed in DS (139).
Neuronal Proliferation
The Sry-related high mobility groove box genes (SOX) in human
have important roles in neuronal proliferation and early devel-
opment. Mutation in SOX3 has shown to be causative in non-
syndromic ID (140). Dichaete is a member of SOX gene family
in Drosophila. This gene is expressed in olfactory bulb neural
precursors and granule cells andwas found to have an influence on
wide range of developmental processes. Dichaete functions in the
development of theCNSby regulating numerous genes (141–143).
In the adult fly brain, dichaete is expressed in glia and neurons of
the olfactory circuit but there is no data on memory formation at
this time (144).
Cytoskeleton, Anchoring Protein, and Cell Adhesion
Receptors need to be properly localized to the synapse to per-
form their function. Several anchoring proteins genes have been
found in patients with ID. Recently, the postsynaptic domain
(PSD) protein SHANK2 gene was identified in ID and ASD cases
throughmicroarrays (145). SHANK2 (also known as prosap) type
of molecules links the actin cytoskeleton to the surface receptors
such as NMDA and mGluR. Thus far only change in alcohol sen-
sitivity has been shown in theDrosophila prosap mutants (146). It
may be interesting to test learning andmemory as severalmemory
mutants had abnormal alcohol sensitivity (147). Mutations in
SHANK3 have also been identified in ID patients. These muta-
tions lead to loss of binding of another PSD protein, Homer (148).
Homer-related proteins are part of large complex responsible
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for structural and functional plasticity of glutamatergic synapses.
In Drosophila, a Homer homolog was identified and found to
be expressed in the nervous system (149). Moreover, courtship
memory was defective in Drosophila homer mutants (149).
Dscam encodes a protein kinase that is required for segregation
of sister branches of the axons of MB neurons (150, 151). It func-
tions by binding extracellularmolecules like netrin and then trans-
ducing the signal from the extra to intra cellular milieu through
Dock and PAK resulting in change in the actin cytoskeleton.
Dscam is translated locally in dendrites and likely contributes to
synaptic plasticity (152). Dscam is regulated by FMRP. FMRP null
mutants have increased Dscam levels, which results in abnormal
behavioral responses and increased error in synaptic targeting
(153, 154). Taken together, dscam provides evidence of a possible
link between DS and FXS (154).
Dfmr1 has also been shown to interact with another ID gene,
Filamin. Some patients with FX presented with periventricular
nodular heterotopia (PNH), a neuronal migration defect asso-
ciated with learning difficulties and seizures (155). PNH was
previously linked to mutation in Filamin. Drosophila mutant for
Filamin homolog, cheerio, were found to have long-term mem-
ory defects. Interestingly, cheerio and dfmr1 interact together in
formation of olfactory long-term memory (156).
Learning and Memory Defects in Intellectual
Disability
Despite the extensive use of behavioral memory assays and elec-
trophysiological models (such as long-term potentiation and
depression) in model organisms of ID genes, there is still signif-
icant gap in our understanding of memory defects in ID. This
is particularly a problem for non-verbal patients. Moreover, co-
morbid problem such as autism and attention deficit have made
memory testing in ID patients more challenging. Here, we will
review the known defects of memory, mostly short-termmemory,
in patients with ID.
As mentioned earlier, the work of Ebbinghaus showed that the
average recall of learning information would be around 30% of
the information learned (20). Several conceptual hypotheses have
been suggested for learning andmemory in ID patients (Figure 4).
One possibility is that patients with ID have no learning and
memory defect (Figure 4B) but rather other general mental abil-
ity defects that limit their cognitive performance. This has been
mostly seen in patients with severe learning disability (157). Alter-
natively, they may have defect of acquisition (Figures 4C,E), con-
solidation (Figure 4D), recall or long-term memory in isolation.
As ID is defined by defect in IQ and adaptive functions, children
may perform the Weschler Intelligence Scale, which includes a
test of digit span memory. This test is given to children aged 7
and above. It requires the child to repeat the digit named either
forward or backward. In many children with ID, the task may be
too difficult to perform. Nonetheless, various studies have aimed
at defining potential memory defects in ID.
Early studies focusing on short-term memory showed defects
in memory in patients with ID when compared to age-matched
subjects (158, 159). Long-term memory studies, when matched
for mental age showed mixed results [reviewed in Ref. (160)].
Some studies found that the defects in ID patients were the con-
sequence of initial encoding defects (159, 161) with the same rate
of forgetting as in control individuals (as in Figure 4E). On the
other hand, others studies showed that the memory decay was
increased in patients with ID (as in Figure 4D). For instance,
Katz (162) showed that individuals with mild and moderate ID
had defects in remembering items (naming of pictures) imme-
diately when compared to college students. When tested at 24 h,
ID patients presented a bigger loss in memory than the college
students did. It is interesting that the college students exhibited
little to no forgetting. This may raise questions about the level
of difficulty of the task and the presence of reconsolidation in
the student group as opposed to the ID patients. In the same
study, memory for the location of object was found to be defective
only in patients with moderate ID. Instruction at the time of
encoding affected the level of memory impairment in patients
with ID. These studies frequently enrolled patients based on the
IQ without knowledge of the etiology of their ID. This may pool
together patients with different learning and memory pattern and
confound the studies.
More recently, studies of memory have been targeting specific
genetic etiology. Studies of Down syndrome patients revealed
that explicit memory was more severely affected in patients with
ID (163). This was noted to be true for short and long-term
memory in explicit memory. Tasks used in these studies included
word lists, word completion, and prose recall. In the same study,
difference in performance betweenDS and ID patients emerged in
learning tasks. For instance, DS patients learned similarly words
that were related or not, but other ID patients did better when
learning words that were related. Also in that study, assessment
of the long-term memory showed that the decay of memory was
similar between normal subjects, patients with Down syndrome,
and other patients with ID (as in Figure 4E). In addition, Carles-
imo (163) showed that implicit memory was actually normal in
individuals with ID (as in Figure 4B).
Selective long-term memory deficit was observed by Vicari
(164) in patients with Williams syndrome (as in Figure 4C).
Patients had to copy Rey Figures at various time points and the
number of items remembered in the figures was scored. Vicari
showed impaired long-term memory due to increased forgetting
rate in patients with Williams syndrome (164).
In contrast to the limited number of studies on long-term
memory, there is a large amount of studies examining working
memory. As noted above, several studies have suggested that the
defect in early stage of encoding and attention are the cause for
poor long-term performance in ID (165). Baddeley’s model of
working memory includes (1) a central executive component,
(2) a phonological loop, and (3) a visuo-spatial sketchpad (166–
168). Each component can be tested separately in patients. Var-
ious degrees of working memory defects have been observed in
children with ID (169–171). Defects in working memory were
observed in children with learning disability even in presence of
normal IQ, which raises the need to distinguish ID from LD in
memory studies (172). Moreover, Henry showed that the level of
performance in the phonological and visual spheres was matched
to the mental age and did not show a specific pattern (173). The
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FIGURE 4 | Scenarios of learning and memory defects in patients
with ID. Several potential scenarios could be proposed to account for
cognitive defects of patients with ID based on previous research findings.
Depending on the gene tested or the method used, these various scenarios
have been observed in ID patients. (A) In control, subjects without ID will be
able to learn a task to criterion and then will present a lower performance in
retest at 24 h. (B) In some rare cases, no learning and memory defects
would be observed. (C) In some patients, defect in learning could be the
sole manifestation. (D) In other patients, they can learn the information but
would not be able to retain it. (E) Finally, in some patients, learning and
long-term memory could be both impaired. The decreased level of learning,
could be responsible for the defect in memory as the actual forgetting levels
are the same as in controls. It should be noted that at this time, there is little
systematic study aimed at identifying which model is most applicable to
each specific genes. These hypothetical scenarios may provide a framework
for the memory investigation in ID.
mean non-verbal IQwas 60 and there were no patients withDown
syndrome in the cohort.
Again, etiology specific defects have been observed. For
instance, Down syndrome patients were found to have defects in
verbal and spatial backward spans (remembering a string of object
but in a reverse manner) aspects of working memory (174). The
IQ in that study was averaged at 36. The patients with DS had
performance similar to ID andmental age-matched subjects when
the task involved remembering the objects in a forward manner.
Another ID population studied extensively is the FX. Short-
term visual and verbal memory defects were identified early on
(175). Working memory defects were shown to be present only
when tasks were complex (176). A signature pattern of defects
in attention, impulsivity and working memory was observed by
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several groups [reviewed in Ref. (177)]. FX patients have defects
in several aspect of working memory: auditory, visuospatial, and
memory for words (178). In the same study, FX patients with ID
were more severely affected.
Insight from Flies Learning and Memory for Drug
Development in ID
Reports from recent large randomized controlled trials failure
questioned the value of pre-clinical research in animal models
(19). There have been important findings from Drosophilamem-
ory research, which could provide insight into how to successfully
translate candidate drugs from the lab to the clinic. Here, we
provide a brief discussion highlighting some factors that need to
be taken into account when thinking about applying basic science
findings in flies to clinical trials. We also speculate on some other
potential pitfalls raised in basic science research that have not yet
been formally tested in ID research.
Protein Domain-Specific Effects on Stage of Memory
Formation
In clinical studies or drug trials, patients are grouped based on
their diagnosis (FXS, NF, etc.). But as shown in the study of
learning and memory in theDrosophilamutants of FXS (113) and
Nf1 (69), different regions of the protein can either affect learning
and/or memory. This may need to be considered in the selection
of the patients for clinical trials as a drug aimed at learningmaynot
have an effect for the patients in whom the mutation affects solely
memory (Figure 4). In addition, cognitive testingmay need to test
attention skills and different phases of memory (workingmemory
and long-term memory) to assess for inter-patients variability,
more homogenous baseline values, and responses to drugs.
Translating Outcome from Homogenized
Backgrounds to Real Populations
Manydrugs are studied in vitro and then in standardized assaywith
animal on a homogenous genetic background. The phenomena of
genetic background-specific gene expression can also provide an
explanation for varying degrees of clinical phenotypes (179). In
Drosophila, MB morphology differs when MB miniature (mbm)
is placed into different genetic backgrounds (180). In addition,
recent data in the arouser (aru)mutant has shown that thememory
defects were variable in function of the background (100).
The Effect of Nutritional Status on Gene Expression
This concept has emerged recently, thanks to two studies pub-
lished last year by the Saitoe (59) and Preat (60) laboratories. They
showed that molecular co-factor of CREB would differ depending
on the fact that the flies were starved prior to long-term memory
training or not. In addition, neuronal activity in key dopaminergic
neurons was altered by starvation. This is important when looking
at children with ID. Indeed, several children will have feeding
abnormalities, with either lack or atypical feeding due to sensory-
processing issues or excess feeding as part of obsessive-compulsive
behaviors (181). This may affect themetabolic state of the patients
and then impact their response to drugs.
Other factors have not been as well documented in Drosophila
but have been suggested from Drosophila research.
Neuronal Network
It is important to consider that information transits from one
brain part to another as memory is learned, consolidated, re-
consolidated, and then recalled. Moreover, the time elapse since
acquisition (short-term versus long-term)may influence in which
part of the brain the memory is located. This has been extensively
studied in Drosophila (32, 182–184). It is therefore important to
characterize the type/stage of memory in animal models and ID
patients when considering transposing a candidate drug. The
increased network complexity in humans CNS (considering for
instance the expansion of the frontal lobe compared to mouse or
rats) may lead to differential reactions between animal models
and human.
Genes can Affect Multiple Pathways
This is well recognized in cancer treatment and infectious resis-
tance. However, this is still poorly understood in ID. Homeostasis
through parallel pathways and receptor turnover can compensate
for modification made with a drug. A good example of a single
gene having effect through multiple pathways is FX (Figures 2
and 3) in which multiple pathways interacting are regulated by
FMRP. This may give raise to phenotypic overlap between syn-
dromes. In addition, it may explain the phenotypic variation
within a given syndrome depending on the burden put on each
pathway by other modifier genes present in an ID patient.
Environmental Effect on Performance
Probably one of the most important issues with animal models
is the fact that conditions are well controlled. Indeed, scientists
studying animal behavior will tell you that rearing, environmental,
and experimental context conditions need to be extremely well
controlled in order to provide successful and reproducible experi-
ments. This “perfect day” scenario is hard to obtain in the clinical
trials, especially with ID children that frequently have sensory-
processing issues, high level of anxiety in novel or test situations,
and obsessive behaviors. Indeed, the comorbidity observed in FXS
patients for instance [reviewed in Ref. (185)] (Figure 1) are fre-
quently observed even in Drosophila and are carefully controlled
in experimental manipulations. These include anxiety (186), sleep
problems (187), and social interaction defects (188). Considering
that anxiety can have a significant and fluctuating effect on ID
patient’s behavior and memory (189), this should be monitored
more closely in trials.
Conclusion
Increasingly sensitive genome-wide techniques have provided
researchers and clinicians with an increasing yield of identifying
specific etiologies in patients with ID (12). This has led to a larger
list of genes involved in ID. Nonetheless, mechanistic insights and
treatments have lagged behind. This gap may become larger if ID
genes to be discovered are of low prevalence and/or small effect.
The memory assays in Drosophila have emerged as important
model to study the molecular basis of cognitive defects linked to
ID genes. Drosophila can also be used to screen pharmacological
compounds for their ability to rescue memory defects observed in
ID model flies. Several pitfalls need to be monitored in order to
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increase the yield of translating findings from the lab into clinical
successes.
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